BioXcel Therapeutics, Inc.
BTAI • NASDAQ • Stock Fundamentals
BioXcel Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Vimal D. Mehta, with a market cap of $34.9M.
Market Cap$34.9M
Employees74.0
CEOVimal D. Mehta
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
BioXcel Therapeutics, Inc. FAQ
Common questions about BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. (BTAI) has a market capitalization of $34.9M and trades on NASDAQ.
BioXcel Therapeutics, Inc. has approximately 74 employees.